My Companies
Notification
Account
Log Out
Back

Bacil Pharma Board Approves ₹50 Crore Rights Issue to Existing Shareholders


9 July 2026
Bacil Pharma Ltd.

Board approved fundraise via Rights Issue of up to Rs 50 Crore and increase in Authorised Share Capital from Rs 20 Crore to Rs 65 Crore. Resignation of two independent directors was noted.


Recent Events

Company Information